April 17, 2026 04:54 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengal SIR: Supreme Court allows voters restored by tribunal till April 21 and 27 to vote | 'Women won't spare you': PM Modi warns Opposition over resistance to quota bill | Vijay booked in 3 cases over poll code violation ahead of Tamil Nadu polls | 'Black law': Stalin burns copy of 'delimitation' bill, slams Modi govt | TCS halts Nashik BPO operations amid sexual abuse, conversion allegations | ‘We are surprised’: SC stays Pawan Khera’s bail over remarks on Himanta Biswa Sarma’s wife | Historic shift: Bihar gets first BJP CM as Samrat Choudhary takes oath | 'ECI deviated from Bihar procedure': Supreme Court raises concerns over voter deletion in Bengal SIR | Noida workers’ protest turns violent: Stones pelted, vehicles damaged over wage hike demand | Oil prices jump above $103 a barrel as US moves to block Iran-linked shipping
Sputnik V | Namibia
Image Credit: twitter page Sputnik V

After South Africa, Namibia also suspends use of Russia's Sputnik V vaccine

| @indiablooms | Oct 25, 2021, at 01:05 am

After South Africa, Namibia has stopped Russia's Sputnik V Covid-19 vaccine citing concerns that it could increase the risk of HIV infection among men, a claim the vaccine's manufacturer says is unfounded, according to media reports.

The Namibian health ministry said in a statement that following South Africa's decision it was suspending, with immediate effect, the use of the jabs until the formula is listed for emergency use by the World Health Organization, reported AFP.

"The reason for discontinuation of the administration of the vaccine is being done out of abundance of caution that men who received Sputnik V may be at higher risk of contracting HIV when exposed to it," said the ministry.

Namibia had taken delivery of a Serbian donation of 30,000 Sputnik doses -- out of which less than 120 have been administered so far.

South Africa's health products regulator said the decision was based on two previous studies, one in South Africa and one in the Americas, on the modified form of adenovirus -- a type of virus that causes respiratory infections -- known as the Ad5 and contained in the jab.

In both trials, "administration of an Ad5-vectored vaccine was associated with enhanced susceptibility/acquisition of HIV in men", the regulator said last week, the AFP report stated.

Russia's Gamaleya Centre, which developed Sputnik V, stated it would bring to fore that SAHPRA's concerns were "completely unfounded".

"Speculation regarding the association between adenovirus type-5 vectored vaccines and HIV transmission in high risk groups has been based on small-scale studies," it said in a statement.    

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.